Depositary Receipt on Becton, Dickinson and Company issued by Kiatnakin Phatra Securities Public Company Limited (BDX06)
SET SET Primary Summary
BDX06 Chart
Depositary Receipt on Becton, Dickinson and Company issued by Kiatnakin Phatra Securities Public Company Limited (BDX06) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Depositary Receipt on Becton, Dickinson and Company issued by Kiatnakin Phatra Securities Public Company Limited ever had a stock split?
Depositary Receipt on Becton, Dickinson and Company issued by Kiatnakin Phatra Securities Public Company Limited Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mr. Thomas E. Polen Jr. CEO | SET Exchange | - ISIN |
| TH Country | 72,000 Employees | - Last Dividend | - Last Split | 1 Jan 1987 IPO Date |
Overview
Becton, Dickinson and Company, commonly known as BD, is a global medical technology company that develops, manufactures, and markets a wide range of medical supplies, devices, laboratory equipment, and diagnostic products. It serves a diversified clientele that includes healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public across the world. BD's business operations are structured into three primary segments: BD Medical, BD Life Sciences, and BD Interventional. Founded in 1897, BD has established its headquarters in Franklin Lakes, New Jersey, demonstrating a longstanding commitment to improving medical care and laboratory research worldwide.
Products and Services
The company's vast array of products and services is categorized into three main segments, each catering to different needs within the healthcare and research sectors.
- BD Medical: This segment provides a broad range of medical technologies designed to enhance the safety and efficiency of healthcare delivery. Products include various types of catheters (peripheral IV, advanced peripheral, central lines, acute dialysis), vascular access and care technologies, needle-free IV connectors, closed-system drug transfer devices, and medication safety systems. Additionally, BD Medical offers medication management solutions, including automated dispensing and inventory systems, along with prefillable drug delivery systems tailored for pharmaceutical use.
- BD Life Sciences: Focused on advancing research and clinical diagnostics, this segment offers products ranging from blood and specimen collection supplies to cutting-edge systems for molecular testing, microorganism identification, and drug susceptibility testing. It provides solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, as well as reagents and kits for gene expression analysis and clinical diagnostics in oncology, immunology, and transplant medicine.
- BD Interventional: This segment specializes in delivering innovative surgical, urology, and critical care products. Its portfolio encompasses hernia and soft tissue repair materials, biosurgery products, peripheral intervention devices, and urology care supplies. The emphasis is on products that facilitate minimal invasive procedures, improve patient outcomes, and reduce the overall cost of care.
